THURSDAY, August 27, 2015 (Discovery News) — An experimental blood test may be able to predict whether a woman with breast cancer will suffer a relapse months before new tumors would be detectable on scans, researchers said Wednesday.
The technology, described in the journal Science Translational Medicine, works by detecting cancer DNA that circulates in the bloodstream.
You might have also missed…
More Patients Are Hearing the Words: ‘You Have Cancer — Again’ Aug 24, Associated Press
Daily dose of aspirin may cut colon cancer risk — but don’t run to the drugstore just yet Aug 26, The Washington Post
9/11 “Dust Lady,” Marcy Borders, dies of cancer Aug 26, CBS News
White House Is Pressed to Help Widen Access to Hepatitis C Drugs via Medicaid Aug 25, The New York Times